CH
Chandrikaben Hasmukh Patel
About Chandrikaben Hasmukh Patel
Data last updated:
Chandrikaben Hasmukh Patel is a Director at Runa Remedies Private Limited (since 2008). The companies operate in Chemicals and Trading. Earlier, Chandrikaben Hasmukh Patel was a Director at Runa Pharma Private Limited (2006–2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Jun 2008 | 2008 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Oct 2006 | 1997 | ₹1.37 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chandrikaben Hasmukh Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hasmukh Babulal Patel | 00053091 | Runa Remedies Private Limited | Director |
| Heena Hasmukhbhai Patel | 09011084 | Runa Remedies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrikaben Hasmukh Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrikaben Hasmukh Patel
Chandrikaben Hasmukh Patel currently holds 1 directorship: Runa Remedies Private Limited (Director, since 23 Jun 2008).
Chandrikaben Hasmukh Patel was first appointed on 01 Oct 2006 as Director at Runa Pharma Private Limited. The most recent appointment on record is 23 Jun 2008 at Runa Remedies Private Limited.
Chandrikaben Hasmukh Patel held 1 earlier board appointment: Runa Pharma Private Limited (Director, 01 Oct 2006 to 15 Apr 2009).
The current boards of Chandrikaben Hasmukh Patel's companies include Hasmukh Babulal Patel (Runa Remedies Private Limited), Heena Hasmukhbhai Patel (Runa Remedies Private Limited).